Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Yulong Eco-Materials Ltd YECO

Healthcare Biotechnology
Yulong Eco-Materials Limited is a holding company. The Company is a manufacturer of building products. The Company's segments include Yulong Bricks; Yulong Concrete and Yulong Transport, and Yulong Renewable. The Yulong Bricks segment is engaged in the production and sale of fly-ash bricks. The Yulong Concrete and Yulong Transport segment is engaged in the production and sale of ready-mixed... see more

Recent & Breaking News (OTCPK:YECO)

EV Biologics Updates on Funding and Sales

Accesswire October 2, 2023

EV Biologics Completes Production of Cutting-Edge MSC Exosome-Based Therapeutic

Accesswire August 16, 2023

EV Biologics Appoints Senior Investment Banker as Corporate Finance Director

Accesswire August 7, 2023

EV Biologics Hires Senior Chief Financial Officer

Accesswire August 2, 2023

EV Biologics Signs Exclusive Distribution Agreement for South America

Accesswire May 15, 2023

EV Biologics Generates Mesenchymal Stem Cell Lines

Accesswire February 21, 2023

EV Biologics Updates on Excyte Subsidiary Funding

Accesswire January 3, 2023

EV Biologics Initiates PCAOB Audit to Seek Uplift to OTCQX

Accesswire November 14, 2022

EV Biologics Launches Excyte with $100 million Valuation

Accesswire August 15, 2022

EV Biologics Signs MSA with LONZA Cell & Gene Therapy

Accesswire May 17, 2022

EV Biologics Isolates Primary Cells for Nanoparticle Production & Accelerated Cell Line Development

Accesswire April 12, 2022

EV Biologics Updates on FINRA Filings

Accesswire March 9, 2022

EV Biologics Updates on FINRA

Accesswire January 18, 2022

EV Biologics Updates on NFT Dividend

Accesswire November 12, 2021

EV Biologics Signs Listing Agreement With INX

Accesswire November 11, 2021

EV Biologics Chief Medical Officer Publication on COVID-19 & Exosomes

Accesswire October 28, 2021

EV Biologics Updates on NFT Minting

Accesswire September 28, 2021

EV Biologics Updates on NFT Warrant Dividend Distribution

Accesswire August 30, 2021

Yulong Eco-Materials Limited Announces NASDAQ Delisting

GlobeNewswire December 13, 2018

Mid-Day Market Update: Fred's Drops After Q3 Results; Adial Pharmaceuticals Shares Surge

Benzinga.com  December 13, 2018